Sara Banon
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: March 11, 2016
Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.
Journal: AIDS (London, England)
Published: February 27, 2016
Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
Journal: AIDS (London, England)
Published: December 20, 2015
Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection.
Journal: Expert review of clinical pharmacology
Published: October 31, 2015
Raltegravir plus two nucleoside analogues as combination antiretroviral therapy in HIV-infected patients who require cancer chemotherapy.
Journal: Antiviral therapy
Published: April 12, 2015
Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
Journal: Digestive diseases and sciences
Published: March 27, 2015
A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance.
Journal: Journal of the International AIDS Society
Published: November 15, 2014
Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients.
Journal: Journal of the International AIDS Society
Published: November 15, 2014
Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis.
Journal: Journal of the International AIDS Society
Published: November 14, 2014
Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy.
Journal: Journal of the International AIDS Society
Published: November 14, 2014
Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity.
Journal: The Journal of antimicrobial chemotherapy
Published: October 12, 2014
Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients.
Journal: Antiviral research
Published: October 07, 2014
Last Updated: 09/26/2026